Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.49 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | FURIN | P09958 | 2/20 | 0.46 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | VIPR2 | P41587 | 1/20 | 0.43 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.43 |
| ▸ | PTH1R | Q03431 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31670624 | 0.91 | TFPI (0.49) | TFPIKEAP1RXFP1FURINIL23R | |
| SCHEMBL29531521 | 0.89 | TFPI (0.45) | TFPIKEAP1RXFP1FURINIL23R | |
| SCHEMBL30942619 | 0.88 | IL23R (0.48) | TFPIRXFP1IL23R | |
| SCHEMBL29442104 | 0.88 | RXFP1 (0.48) | TFPIKEAP1RXFP1VIPR2PTH1R | |
| SCHEMBL30432423 | 0.86 | TFPI (0.61) | TFPIRXFP1VIPR2PTH1R | |
| SCHEMBL31737509 | 0.86 | IL23R (0.45) | KEAP1IL23ROPRL1 | |
| SCHEMBL26886898 | 0.86 | NPY4R (0.46) | KEAP1 | |
| SCHEMBL30974358 | 0.85 | TFPI (0.57) | TFPIRXFP1VIPR2 | |
| SCHEMBL30976568 | 0.84 | FURIN (0.48) | TFPIRXFP1FURINPRSS1 | |
| SCHEMBL30148472 | 0.84 | TFPI (0.47) | TFPIRXFP1FURINPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3897693-B1 | SYNTHETIC AND RECOMBINANT COLLAGEN PEPTIDES HAVING BIOLOGICAL ACTIVITY | GELITA AG (DE) | 2025-08-06 | — | — | EP | disclosed |